Platelet-derived growth factor-BB, insulin-like growth factor-I, and phorbol ester activate different signaling pathways for stimulation of vascular smooth muscle cell migration

Experimental Cell Research

Volumn 242, Issue 2, 1998, Pages 548-560

  Pukac, Laurie ^a   Huangpu, Jun ^a   Karnovsky, Morris J ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

IGF 1; Migration; PDGF BB; Protein kinase C; Signaling; Smooth muscle

Indexed keywords

PHORBOL ESTER; PLATELET DERIVED GROWTH FACTOR BB; SOMATOMEDIN C;

ANIMAL CELL; ARTICLE; CELL MIGRATION; CELL STIMULATION; ENZYME ANALYSIS; ENZYME INHIBITION; ENZYME REGULATION; NONHUMAN; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION; VASCULAR SMOOTH MUSCLE;

ANIMALIA;

EID: 0032145417     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1006/excr.1998.4138     Document Type: Article

References (69)

1. Virmani R., Farb A., Burke A. Coronary angioplasty from the perspective of atherosclerotic plaque: Morphologic predictors of immediate success and restenosis. Am. Heart J. 127:1994;163-179.
2. Davies M. G., Hagen P. O. Pathobiology of intimal hyperplasia. Br. J. Surg. 81:1994;1254-1269.
3. Miano J. M., Vlasic N., Tota R., Stemerman M. B. Smooth muscle cell immediate-early gene and growth factor activation follows vascular injury. Arterioscler. Thromb. 13:1993;211-219.
4. Hayry P., Myllarniemi M., Aavik E., Alatalo S., Aho P., Yilmax S., Raisanen-Sokolowski A., Cozzone G., Jameson B., Baserga R. Stabile D-peptide analog of insulin-like growth factor-1 inhibits smooth muscle cell proliferation after carotid ballooning injury in the rat. FASEB J. 9:1995;1336-1344.
5. Schwartz S. Smooth muscle migration in atherosclerosis and restenosis. J. Clin. Invest. 99:1997;2814-2817.
6. Abedi H., Zachary I. Signalling mechanisms in the regulation of vascular cell migration. Cardiovasc. Res. 30:1995;544-556.
7. Jawien A., Bowen-Pope D., Lindner V., Schwartz S., Clowes A. Platelet-derived growth factor promotes smooth muscle migration and intimal thickening in a rat model of balloon angioplasty. J. Clin. Invest. 89:1992;507-511.
8. Jackson C., Raines E., Ross R., Reidy M. Role of endogenous platelet-derived growth factor in arterial smooth muscle cell migration after balloon catheter injury. Arterioscler. Thromb. 13:1993;1218-1226.
9. Hughes A., Clunn G., Refson J., Demoliou-Mason C. Platelet-derived growth factor (PDGF): Actions and mechanisms in vascular smooth muscle. Gen. Pharmacol. 27:1996;1079-1089.
10. Arnqvist H., Bornfeldt K., Chen Y., Lindstrom T. The insulin-like growth factor system in vascular smooth muscle: Interaction with insulin and growth factors. Metabolism. 44:1995;58-66.
11. Jones J., Doerr M., Clemmons D. Cell migration: Interactions among integrins, IGFs, and IGFBPs. Prog. Growth Factor Res. 6:1995;319-327.
12. Koyama N., Hart C., Clowes A. Different functions of the platelet-derived growth factor-α and -β receptors for the migration and proliferation of cultured baboon smooth muscle cells. Circ. Res. 75:1994;682-691.
13. Pauly R., Bilato C., Sollott S., Monticone R., Kelly P., Lakatta E., Crow M. Role of calcium/calmodulin-dependent protein kinase II in the regulation of vascular smooth muscle cell migration. Circulation. 91:1995;1107-1115.
14. Anand-Apte B., Zetter B. Signaling mechanisms in growth factor-stimulated cell motility. Stem Cells. 15:1997;259-267.
15. Newton A. Regulation of protein kinase C. Curr. Opin. Cell Biol. 9:1997;161-167.
16. Ohanian V., Ohanian J., Shaw L., Scarth S., Parker P., Heagerty A. Identification of protein kinase C isoforms in rat mesenteric small arteries and their possible role in agonist-induced contraction. Circ. Res. 78:1996;806-812.
17. Leng L., Du B., Consigli S., McCaffrey T. Translocation of protein kinase C-delta by PDGF in cultured vascular smooth muscle cells. Artery. 22:1996;140-154.
18. Daum G., Hedin U., Wang Y., Wang T., Clowes A. Diverse effects of heparin on mitogen-activated protein kinase-dependent signal transduction in vascular smooth muscle cells. Circ. Res. 81:1997;17-23.
19. Seger R., Krebs E. The MAPK signaling cascade. FASEB J. 9:1995;726-735.
20. Denhardt D. Signal-transducing protein phosphorylation cascades mediated by Ras/Rho proteins in the mammalian cell: The potential for multiplex signalling. Biochem. J. 318:1996;729-747.
21. Bornfeldt K. E., Raines E. W., Nakano T., Graves L. M., Krebs E. G., Ross R. Insulin-like growth factor-1 and platelet-derived growth factor-BB induce directed migration of human arterial smooth muscle cells via signaling pathways that are distinct from those of proliferation. J. Clin. Invest. 93:1994;1266-1274.
22. Jiang B., Yamamura S., Nelson P., Mureebe L., Kent K. Differential effects of platelet-derived growth factor isotypes on human smooth muscle cell proliferation and migration are mediated by distinct signaling pathways. Surgery. 120:1996;427-432.
23. Graf K., Xi X., Yang D., Fleck E., Hsueh W., Law R. Mitogen-activated protein kinase activation is involved in platelet-derived growth factor-directed migration by vascular smooth muscle cells. Hypertension. 29:1997;334-339.
24. Clowes A. W., Karnovsky M. J. Suppression by heparin of smooth muscle proliferation in injured arteries. Nature. 265:1977;625-626.
25. Karnovsky M. J., Edelman E. R. Heparin/heparan sulphate regulation of vascular smooth muscle cell behavior. Airways and Vascular Remodelling. 1994;Academic Press, San Diego. p. 45-69.
26. Majack R., Clowes A. Inhibition of vascular smooth muscle cell migration by heparin-like glycosaminoglycans. J. Cell. Physiol. 118:1984;253-256.
27. Clowes A., Clowes M. Kinetics of cellular proliferation after arterial injury. IV. Heparin inhibits rat smooth muscle mitogenesis and migration. Circ. Res. 58:1986;839-845.
28. Geary R., Koyama N., Wangs T., Vergel S., Clowes A. Failure of heparin to inhibit intimal hyperplasia in injured baboon arteries. Circulation. 91:1995;2972-2981.
29. Au Y., Kenagy R., Clowes M., Clowes A. Mechanisms of inhibition by heparin of vascular smooth muscle cell proliferation and migration. Haemostasis. 23:1993;177-182.
30. Herbert J., Bono F., Lamarche I., Carmeliet P. The inhibitory effect of heparin for vascular smooth muscle cell proliferation or migration is not mediated by u-PA and t-PA. Thromb. Res. 86:1997;317-324.
31. Pukac L. A., Ottlinger M. E., Karnovsky M. J. Heparin suppresses specific second messenger pathways for protooncogene expression in rat vascular smooth muscle cells. J. Biol. Chem. 267:1992;3707-3711.
32. Ottlinger M. E., Pukac L. A., Karnovsky M. J. Heparin inhibits mitogen-activated protein kinase activation in intact rat vascular smooth muscle cells. J. Biol. Chem. 268:1993;19173-19176.
33. Herbert J., Clowes M., Lea H., Pascal M., Clowes A. Protein kinase C α expression is required for heparin inhibition of rat smooth muscle cell proliferation in vitro and in vivo. J. Biol. Chem. 271:1996;25928-25935.
34. Pukac L., Carter J., Ottlinger M., Karnovsky M. Mechanisms of inhibition by heparin of PDGF stimulated MAP kinase activation in vascular smooth muscle cells. J. Cell. Physiol. 172:1997;69-78.
35. Mii S., Ware J. A., Kent K. C. Transforming growth factor-beta inhibits human vascular smooth muscle cell growth and migration. Surgery. 114:1993;464-470.
36. Tannenbaum J., Waleh N., Mauray F., Breuss J., Pytela R., Kramer R., Clyman P. Transforming growth factor β1 inhibits fetal lamb ductus arteriosus smooth muscle cell migration. Pediatr. Res. 37:1995;561-570.
37. Bell L., Madri J. Effect of platelet factors on migration of cultured bovine aortic endothelial and smooth muscle cells. Circ. Res. 65:1989;1057-1065.
38. Petzelbauer E., Springhorn J., Tucker A., Madri J. Role of plasminogen activator inhibitor in the reciprocal regulation of bovine aortic endothelial and smooth muscle cell migration by TGF-β1. Am. J. Pathol. 149:1996;923-931.
39. Snow A. D., Bolender R. P., Wight T. N., Clowes A. W. Heparin modulates the composition of the extracellular matrix domain surrounding arterial smooth muscle cells. Am. J. Pathol. 137:1990.
40. Murugesan G., Chisolm G., Fox P. Oxidized low density lipoprotein inhibits the migration of aortic endothelial cells in vitro. J. Cell Biol. 120:1993;1011-1019.
41. Sarkar R., Meinberg E., Stanley J., Gordon D., Webb R. Nitric oxide reversibly inhibits the migration of cultured vascular smooth muscle cells. Circ. Res. 78:1996;225-230.
42. Pukac L. A., Hirsch G. M., Lormeau J. C., Petitou M., Choay J., Karnovsky M. J. Antiproliferative effects of novel, nonanticoagulant heparin derivatives on vascular smooth muscle cells in vitro and in vivo. Am. J. Pathol. 139:1991;1501-1509.
43. Edelman E. R., Adams D. H., Karnovsky M. J. Effect of controlled adventitial heparin delivery on smooth muscle cell proliferation following endothelial injury. Proc. Natl. Acad. Sci. USA. 87:1990;3773-3777.
44. Ui M., Okada T., Jazeki K., Hazeki O. Wortmannin as a unique probe for an intracellular signalling protein, phosphoinositide 3-kinase. Trends Biochem. Sci. 20:1995;303-307.
45. Nakamura M., Nakashima S., Katagiri Y., Nozawa Y. Effect of wortmannin and 2-(4-morpholinyl)-8-phenyl-4HN. Biochem. Pharmacol. 53:1997;1929-1936.
46. Natarajan V., Vepa S., al-Hassani M., Scribner W. The enhancement by wortmannin of protein kinase C-dependent activation of phospholipase D in vascular endothelial cells. Chem. Phys. Lipids. 86:1997;65-74.
47. Simonson M., LePage D., Walsh K. Rapid characterization of growth-arrest genes in transient transfection assays. BioTechniques. 18:1995;434-442.
48. Pukac L., Carter J., Morrison K., Karnovsky M. Enhancement of diaminobenzidine (DAB) colorimetric signal in immunoblotting. BioTechniques. 23:1997;385-388.
49. Davis P., Hill C., Keech E., Lawton G., Nixon J., Sedgwick A., Wadsworth J., Westmacott E., Wilkinson S. Potent selective inhibitors of protein kinase C. FEBS Lett. 259:1989;61-63.
50. Harris T., Persaud S., Jones P. Atypical isoforms of PKC and insulin secretion from pancreatic beta-cells: Evidence using Go 6976 and Ro 31-8220 as PKC inhibitors. Biochem. Biophys. Res. Commun. 227:1996;672-676.
51. Wilkinson S., Parker P., Nixon J. Isoenzyme specificity of bisindolymaleimides, selective inhibitors of protein kinase C. Biochem J. 294:1993;335-337.
52. Newby A., Lim K., Evans M., Brindle N., Booth R. Inhibition of rabbit aortic smooth muscle cell proliferation by selective inhibitors of protein kinase C. Br. J. Pharmacol. 114:1995;1652-2656.
53. Lee M., Severson D. Signal transduction in vascular smooth muscle: Diacylglycerol second messengers and PKC action. Am. J. Physiol. 267:1994;C659-C678.
54. Alessi D., Cuenda A., Cohen P., Dudley D., Saltiel A. PD 098059 is a specific inhibitor of the activation of mitogen-activated protein kinase kinase in vitro and in vivo. J. Biol. Chem. 270:1995;27489-27494.
55. Pang L., Sawada T., Decker S., Saltiel A. Inhibition of MAP kinase kinase blocks the differentiation of PC-12 cells induced by nerve growth factor. J. Biol. Chem. 270:1995;13585-13588.
56. Klemke R., Cai S., Giannini A., Gallagher P. Regulation of cell motility by mitogen-activated protein kinase. J. Cell Biol. 137:1997;481-492.
57. Grammer T., Blenis J. Evidence for MEK-independent pathways regulating the prolonged activation of the ERK-MAP kinases. Oncogene. 14:1997;1635-1642.
58. Higaki M., Sakaue H., Ogawa W., Kasuga M., Shimokado K. Phosphatidylinositol 3-kinase-independent signal transduction pathways for platelet-derived growth factor-induced chemotaxis. J. Biol. Chem. 271:1996;29342-29346.
59. Poon M., Marx S., Gallo R., Badimon J., Taubman M., Marks A. Rapamycin inhibits vascular smooth muscle cell migration. J. Clin. Invest. 98:1996;2277-2283.
60. Toker A., Meyer M., Reddy K., Falck J., Aneja R., Aneja S., Parra A., Burns D., Ballas L., Cantley L. Activation of protein kinase C family members by the novel polyphosphoinositides PI-3,4-P2 and PI-3,4,5-P3. J. Biol. Chem. 269:1994;32358-32367.
61. Akinoto K., Takahashi R., Moriya S., Nishioka N., Takayanagi J., Kimura K., Fukui Y., Osada S., Mizuno K., Hirai S., Kazlauskas A., Ohno S. EGF or PDGF receptors activate atypical PKCλ through phosphatidylinositol 3-kinase. EMBO J. 15:1996;788-798.
62. Kiss Z., Tomono M. Wortmannin has opposite effects on phorbol ester-induced DNA synthesis and phosphatidylcholine hydrolysis. FEBS Lett. 371:1995;185-187.
63. Langan E., Youkey J., Elmore J., Franklin D., Singer H. Regulation of MAP kinase activity by growth stimuli in vascular smooth muscle. J. Surg. Res. 57:1994;215-220.
64. Person J., Lovett D., Raugi G. Modulation of mesangial cell migration by extracellular matrix components. Am. J. Pathol. 133:1988;609-614.
65. Kolodgie F., Jacob A., Wilson P., Carlson G., Farb A., Verma A., Virmani R. Estradiol attenuates directed migration of vascular smooth muscle cells in vitro. Am. J. Pathol. 148:1996;969-976.
66. Castellot J. J., Pukac L. A., Caleb B. L., Wright T. C., Karnovsky M. J. Heparin selectively inhibits a protein kinase C dependent mechanism of cell cycle progression in calf aortic smooth muscle cells. J. Cell Biol. 109:1989;3147-3156.
67. Thyberg J., Hultgardh-Nilsson A. Fibronectin and the basement membrane components laminin and collagen type IV influence the phenotypic properties of subcultured rat aortic smooth muscle cells differently. Cell Tissue Res. 276:1994;263-271.
68. Nelson P., Yamamura S., Kent K. Platelet-derived growth factor and extracellular matrix proteins provide a synergistic stimulus for human vascular smooth muscle cell migration. J. Vasc. Surg. 26:1997;104-112.
69. Koyama N., Morisaki N., Saito Y., Yoshida S. Regulatory effects of platelet-derived growth factor-AA homodimer on migration of vascular smooth muscle cells. J. Biol. Chem. 32:1992;22806-22812.